"Ketorolac: To Bleed Or Not To Bleed? That Is The Question" by Elisabeth E. Stewart
 

Faculty Advisor(s)

Elisha Coppens

Document Type

Capstone

Publication Date

Spring 2023

Rights

© 2023 the Author

Abstract

Ketorolac is a readily available, inexpensive, moderate to severe pain management adjunct. As opioids lost favor, ketorolac gained popularity, as an opioid-sparing alternative (Corsini et al., 2021). Anecdotally, surgeons have been resistant to intra-operative intravenous ketorolac due to perceived bleeding risks. As such, this review seeks to evaluate the literature to determine whether ketorolac administration is associated with clinically significant bleeding in adult breast surgery patients. The results demonstrated conflicting evidence for ketorolac use. No literature has established a causal relationship between ketorolac and clinically significant bleeding. Future research avenues include geriatric, pediatric, labor and delivery, dosing, and randomized control trials.

Comments

MSNA Capstone

Download

Plum Print visual indicator of research metrics
PlumX Metrics
  • Usage
    • Abstract Views: 136
    • Downloads: 83
see details

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.